Physician
New York City Health and Hospitals Corporation
New York City Health and Hospitals Corporation was paid $57.46M by Medicaid between Jan 2018 and Dec 2024, across 322 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 14% of everything it billed.
33Billing provider infoNEW YORK CITY HEALTH AND HOSPITALS CORPORATION
NEW YORK, NY 10002
NEW YORK, NY 10002
33aNPI1548208127assigned 06/03/2006
33bProvider typeInternal Medicine Physician
28Total paid$57.46M
24GClaims1,251,300
24DCodes billed322
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#11 of 6,049
Median peer was paid$11K
This provider vs. median5,080×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,804 | $1.34M | |
| 2019 | 97,683 | $4.64M | |
| 2020 | 204,485 | $10.43M | |
| 2021 | 294,825 | $13.40M | |
| 2022 | 217,869 | $10.27M | |
| 2023 | 207,684 | $8.77M | |
| 2024incomplete | 200,950 | $8.61M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 93,847 | 74,720 | $8.12M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 12% | 56,339 | 28,696 | $6.99M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.4% | 54,140 | 44,002 | $3.70M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.3% | 31,574 | 25,386 | $3.04M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 3.3% | 19,159 | 12,683 | $1.89M |
| 99441 | 3.1% | 26,449 | 24,677 | $1.81M | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.1% | 24,802 | 19,484 | $1.77M |
| 99442 | 3.0% | 20,974 | 19,845 | $1.74M | |
| H2012 | Behavioral health day treatment, per hour | 2.1% | 14,825 | 1,706 | $1.21M |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 115,583 | 47,637 | $1.11M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.7% | 12,569 | 8,036 | $965K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 10,339 | 7,583 | $848K |
310 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.5% | 9,985 | $839K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.4% | 13,895 | $811K |
| D0999 | Unspecified diagnostic procedure, by report | 1.3% | 4,710 | $753K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 6,147 | $715K |
| D9999 | Unspecified adjunctive procedure, by report | 1.2% | 4,823 | $695K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.2% | 20,887 | $680K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.1% | 16,998 | $618K |
| D0120 | Dental checkup, returning patient | 1.1% | 23,297 | $615K |
| 99203 | Doctor's office visit, new patient (routine) | 1.0% | 4,995 | $580K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 8,710 | $560K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 28,358 | $554K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 7,842 | $548K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 4,327 | $548K |
| 99443 | <1% | 6,061 | $536K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 4,570 | $523K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 15,536 | $511K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 21,967 | $496K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,980 | $469K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 2,260 | $431K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,040 | $424K |
| 90750 | <1% | 2,426 | $388K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,815 | $383K |
| 90651 | <1% | 2,849 | $371K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 7,853 | $367K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,120 | $362K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 3,180 | $350K |
| 80061 | Lipid panel | <1% | 24,375 | $292K |
| 86480 | <1% | 4,040 | $256K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 10,209 | $254K |
| 90461 | <1% | 4,859 | $250K | |
| D1110 | Prophylaxis - adult | <1% | 5,377 | $238K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 28,436 | $232K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,363 | $207K |
| 86703 | <1% | 14,154 | $207K | |
| 99385 | <1% | 1,471 | $198K | |
| 90686 | <1% | 12,350 | $192K | |
| 90677 | <1% | 1,168 | $188K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 3,822 | $175K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,213 | $174K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12,400 | $171K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,844 | $161K |
| 80053 | Comprehensive metabolic panel | <1% | 13,595 | $159K |
| 85027 | <1% | 28,630 | $154K | |
| 81003 | <1% | 10,382 | $151K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,116 | $150K |
| 87536 | <1% | 1,466 | $145K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 901 | $145K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 15,362 | $141K |
| 92015 | Determination of refractive state | <1% | 6,198 | $136K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 3,170 | $136K |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 8,080 | $133K |
| 90746 | <1% | 2,133 | $131K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,695 | $131K |
| 99051 | <1% | 5,435 | $124K | |
| 86780 | <1% | 9,621 | $124K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,135 | $118K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 3,308 | $110K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 5,688 | $110K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 673 | $107K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,040 | $106K |
| 80076 | <1% | 12,299 | $105K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,566 | $102K |
| 86803 | <1% | 8,012 | $99K | |
| 92250 | <1% | 2,283 | $97K | |
| 86360 | <1% | 1,812 | $96K | |
| 99386 | <1% | 619 | $94K | |
| 86769 | <1% | 2,919 | $90K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 5,111 | $90K |
| 97161 | <1% | 870 | $86K | |
| 90715 | <1% | 2,845 | $82K | |
| 81408 | <1% | 58 | $79K | |
| 86359 | <1% | 1,811 | $75K | |
| D1120 | Dental cleaning, child | <1% | 2,266 | $74K |
| 0012A | <1% | 1,753 | $73K | |
| 87800 | <1% | 1,909 | $72K | |
| 99381 | <1% | 723 | $67K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,641 | $67K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,901 | $66K |
| 92083 | <1% | 1,018 | $64K | |
| 96127 | <1% | 10,038 | $63K | |
| 0064A | <1% | 1,455 | $63K | |
| 90697 | <1% | 463 | $62K | |
| 0011A | <1% | 1,831 | $61K | |
| 87340 | <1% | 6,208 | $61K | |
| 91322 | <1% | 552 | $57K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 1,018 | $57K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 130 | $56K |
| 86706 | <1% | 5,634 | $56K | |
| 00120 | <1% | 989 | $55K | |
| 90480 | <1% | 1,195 | $55K | |
| 82728 | <1% | 4,302 | $54K | |
| 88142 | <1% | 2,324 | $53K | |
| 73630 | <1% | 1,442 | $52K | |
| H2010 | Comprehensive medication services, per 15 minutes | <1% | 824 | $49K |
| 83655 | <1% | 3,670 | $48K | |
| 92133 | <1% | 1,178 | $46K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,372 | $42K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 959 | $41K |
| 76827 | <1% | 1,172 | $41K | |
| 81025 | <1% | 6,103 | $40K | |
| 82607 | <1% | 2,787 | $38K | |
| 99201 | <1% | 446 | $36K | |
| 87486 | <1% | 1,052 | $35K | |
| 90836 | <1% | 392 | $35K | |
| 82274 | <1% | 2,711 | $35K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 248 | $33K |
| 87581 | <1% | 1,051 | $33K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,146 | $32K |
| 90732 | <1% | 336 | $32K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 287 | $30K |
| G0467 | Community health center visit, returning patient | <1% | 8,896 | $30K |
| 99383 | <1% | 226 | $29K | |
| 86704 | <1% | 2,728 | $29K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,846 | $28K |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | <1% | 44 | $28K |
| 81001 | <1% | 6,474 | $27K | |
| 86762 | <1% | 1,945 | $27K | |
| 99205 | Prolong outpt/office vis | <1% | 154 | $26K |
| D1351 | Sealant - per tooth | <1% | 1,191 | $25K |
| 0134A | <1% | 572 | $25K | |
| 3074F | <1% | 23,230 | $24K | |
| 86765 | <1% | 1,951 | $24K | |
| 82043 | <1% | 4,478 | $24K | |
| D0274 | Bitewings - four radiographic images | <1% | 2,736 | $24K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 556 | $23K |
| 84153 | <1% | 1,402 | $23K | |
| 90734 | <1% | 941 | $23K | |
| 99384 | <1% | 150 | $22K | |
| 87535 | <1% | 596 | $21K | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 1,056 | $21K |
| 90670 | <1% | 1,379 | $20K | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 397 | $20K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 107 | $20K |
| 83550 | <1% | 2,692 | $20K | |
| 90739 | <1% | 128 | $20K | |
| 86787 | <1% | 1,808 | $20K | |
| 90620 | <1% | 160 | $20K | |
| 84439 | <1% | 2,222 | $19K | |
| 76642 | <1% | 218 | $19K | |
| 90707 | <1% | 527 | $18K | |
| 87631 | <1% | 140 | $18K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 3,599 | $17K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 160 | $17K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 1,395 | $16K |
| 83540 | <1% | 2,780 | $16K | |
| 76830 | Ultrasound, transvaginal | <1% | 131 | $16K |
| 0124A | <1% | 317 | $15K | |
| 90656 | <1% | 1,117 | $15K | |
| 92134 | <1% | 347 | $14K | |
| 83001 | <1% | 767 | $14K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 468 | $14K |
| 90662 | <1% | 563 | $14K | |
| 86003 | <1% | 236 | $14K | |
| 92551 | <1% | 506 | $13K | |
| 86735 | <1% | 1,175 | $13K | |
| 99382 | <1% | 106 | $13K | |
| 84146 | <1% | 673 | $13K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,629 | $12K |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 112 | $12K |
| 97803 | <1% | 434 | $12K | |
| 90714 | <1% | 493 | $12K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 863 | $11K |
| 90716 | <1% | 365 | $11K | |
| 83020 | <1% | 779 | $11K | |
| 0154A | <1% | 233 | $10K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 467 | $10K |
| 87081 | <1% | 1,395 | $10K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 159 | $10K |
| 84702 | <1% | 730 | $10K | |
| 77065 | Tomosynthesis, mammo | <1% | 73 | $9K |
| 87517 | <1% | 202 | $9K | |
| 81161 | <1% | 45 | $9K | |
| 86850 | <1% | 651 | $8K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 89 | $8K |
| D0140 | Limited oral evaluation - problem focused | <1% | 276 | $8K |
| 0072A | <1% | 165 | $8K | |
| 90633 | <1% | 1,000 | $8K | |
| 82951 | <1% | 698 | $7K | |
| 0081A | <1% | 157 | $7K | |
| 81329 | <1% | 56 | $7K | |
| 90674 | <1% | 246 | $7K | |
| 84403 | <1% | 247 | $6K | |
| 99173 | <1% | 982 | $6K | |
| 96161 | <1% | 888 | $6K | |
| 0071A | <1% | 121 | $6K | |
| 86901 | <1% | 940 | $6K | |
| 0082A | <1% | 120 | $5K | |
| 86592 | <1% | 997 | $5K | |
| 86900 | <1% | 930 | $5K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 98 | $5K |
| 87338 | <1% | 405 | $5K | |
| 86140 | <1% | 1,068 | $5K | |
| 76536 | <1% | 39 | $5K | |
| 99429 | <1% | 62 | $5K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 1,489 | $5K |
| 81243 | <1% | 100 | $5K | |
| 99188 | <1% | 217 | $5K | |
| G0435 | Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening | <1% | 343 | $4K |
| D0272 | Bitewings - two radiographic images | <1% | 574 | $4K |
| 80348 | <1% | 172 | $4K | |
| Q3014 | Telehealth originating site facility fee | <1% | 167 | $4K |
| 85610 | <1% | 1,076 | $4K | |
| 96112 | <1% | 27 | $4K | |
| 0074A | <1% | 78 | $4K | |
| 86008 | <1% | 29 | $4K | |
| 77061 | <1% | 31 | $4K | |
| 51798 | <1% | 84 | $3K | |
| 0004A | <1% | 69 | $3K | |
| 84402 | <1% | 127 | $3K | |
| 87186 | <1% | 321 | $3K | |
| 82105 | <1% | 218 | $3K | |
| 86708 | <1% | 282 | $3K | |
| 86593 | <1% | 658 | $3K | |
| 90694 | <1% | 91 | $3K | |
| 90680 | <1% | 592 | $3K | |
| 90698 | <1% | 641 | $3K | |
| 81361 | <1% | 26 | $3K | |
| 86038 | <1% | 283 | $3K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 417 | $3K |
| 91320 | <1% | 65 | $3K | |
| D1206 | Topical application of fluoride varnish | <1% | 281 | $3K |
| 82785 | <1% | 174 | $3K | |
| 82670 | <1% | 92 | $3K | |
| 90653 | <1% | 138 | $3K | |
| 94060 | <1% | 25 | $3K | |
| 85651 | <1% | 693 | $2K | |
| 96116 | <1% | 14 | $2K | |
| 81401 | <1% | 26 | $2K | |
| 90474 | <1% | 139 | $2K | |
| 83735 | <1% | 401 | $2K | |
| 81002 | <1% | 42 | $2K | |
| 81405 | <1% | 13 | $2K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 337 | $2K |
| 99401 | <1% | 40 | $2K | |
| D4341 | <1% | 25 | $2K | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 49 | $2K |
| 99493 | <1% | 12 | $2K | |
| 83002 | <1% | 95 | $2K | |
| 90838 | <1% | 15 | $2K | |
| 91319 | <1% | 189 | $2K | |
| 90744 | <1% | 248 | $2K | |
| 81257 | <1% | 26 | $2K | |
| 83516 | <1% | 138 | $2K | |
| 92020 | <1% | 50 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 167 | $1K |
| 73610 | <1% | 27 | $1K | |
| 58300 | <1% | 12 | $1K | |
| 74220 | <1% | 39 | $1K | |
| 90710 | <1% | 133 | $1K | |
| 88141 | <1% | 60 | $1K | |
| 73560 | <1% | 41 | $1K | |
| G0466 | Community health center visit, new patient | <1% | 135 | $1K |
| 92225 | <1% | 48 | $1K | |
| 97802 | <1% | 92 | $1K | |
| 81255 | <1% | 26 | $1K | |
| 81251 | <1% | 26 | $1K | |
| 81200 | <1% | 26 | $1K | |
| 81400 | <1% | 26 | $997.83 | |
| 73030 | <1% | 26 | $961.66 | |
| 81260 | <1% | 26 | $888.39 | |
| 1159F | <1% | 3,848 | $887.64 | |
| 83970 | <1% | 24 | $882.66 | |
| 0073A | <1% | 18 | $880.01 | |
| 92227 | <1% | 28 | $859.66 | |
| 91318 | <1% | 85 | $804.36 | |
| 90678 | <1% | 17 | $745.23 | |
| 90696 | <1% | 101 | $728.05 | |
| 84100 | <1% | 177 | $682.47 | |
| 87522 | Neg quan hep c or qual rna | <1% | 16 | $644.90 |
| 90672 | <1% | 147 | $605.53 | |
| 90473 | <1% | 33 | $521.48 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 169 | $495.87 |
| 82746 | <1% | 25 | $436.33 | |
| 84550 | <1% | 93 | $431.79 | |
| 85730 | <1% | 68 | $346.85 | |
| 96160 | <1% | 18 | $333.30 | |
| 92202 | <1% | 16 | $320.86 | |
| 96159 | <1% | 13 | $318.89 | |
| 90713 | <1% | 12 | $304.70 | |
| 82465 | <1% | 69 | $301.62 | |
| 90688 | <1% | 56 | $287.45 | |
| 84425 | <1% | 13 | $244.55 | |
| 82172 | <1% | 12 | $203.56 | |
| 90660 | <1% | 25 | $193.44 | |
| 82977 | <1% | 24 | $167.40 | |
| 82948 | <1% | 42 | $164.08 | |
| D0330 | Panoramic radiographic image | <1% | 15 | $151.27 |
| 83695 | <1% | 12 | $148.78 | |
| 90700 | <1% | 24 | $147.62 | |
| 86430 | <1% | 15 | $81.50 | |
| 82570 | <1% | 14 | $66.30 | |
| 85045 | <1% | 17 | $62.15 | |
| 90648 | <1% | 12 | $53.55 | |
| 84156 | <1% | 15 | $51.31 | |
| 85018 | <1% | 19 | $45.38 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $29.54 |
| 81000 | <1% | 15 | $29.15 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 18 | $20.53 |
| G0008 | Administration of influenza virus vaccine | <1% | 185 | $2.67 |
| 90611 | <1% | 109 | $0.05 | |
| 3079F | 0% | 8,139 | $0.00 | |
| 3080F | 0% | 1,300 | $0.00 | |
| 3075F | 0% | 5,038 | $0.00 | |
| 1220F | 0% | 512 | $0.00 | |
| 3044F | 0% | 50 | $0.00 | |
| 3077F | 0% | 2,619 | $0.00 | |
| 1160F | 0% | 2,435 | $0.00 | |
| 3078F | 0% | 20,373 | $0.00 | |
| 99499 | 0% | 1,665 | $0.00 | |
| 2022F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKARLIN, MARJI (CHIEF REVENUE OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.